Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer.
about
Mechanisms of drug resistance in colon cancer and its therapeutic strategiesPlasma membrane transporters in modern liver pharmacologyRole of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistanceFluoropyrimidine ActivityExpression of BAF57 in ovarian cancer cells and drug sensitivity.The c-MYC-ABCB5 axis plays a pivotal role in 5-fluorouracil resistance in human colon cancer cells.Three-dimensional structure of the human breast cancer resistance protein (BCRP/ABCG2) in an inward-facing conformation.Protein profiling of ovarian cancers by immunohistochemistry to identify potential target pathways.Oxazaphosphorine bioactivation and detoxification The role of xenobiotic receptors.Identification of GAS1 as an epirubicin resistance-related gene in human gastric cancer cells with a partially randomized small interfering RNA libraryExpression of the breast cancer resistance protein and 5-fluorouracil resistance in clinical breast cancer tissue specimens.Drug Resistance Mechanisms in Non-Small Cell Lung Carcinoma.Human ABCG2: structure, function, and its role in multidrug resistance.Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters.The homeobox gene MSX2 determines chemosensitivity of pancreatic cancer cells via the regulation of transporter gene ABCG2.Ibuprofen is a non-competitive inhibitor of the peptide transporter hPEPT1 (SLC15A1): possible interactions between hPEPT1 substrates and ibuprofen.PharmGKB summary: fluoropyrimidine pathwaysABCB1 gene polymorphisms are associated with adverse reactions in fluoropyrimidine-treated colorectal cancer patients.APE1/Ref-1 knockdown in pancreatic ductal adenocarcinoma - characterizing gene expression changes and identifying novel pathways using single-cell RNA sequencing.The phytoestrogens daidzein and equol inhibit the drug transporter BCRP/ABCG2 in breast cancer cells: potential chemosensitizing effect.Preventing chemotherapy-induced myelosuppression by repurposing the FLT3 inhibitor quizartinib.
P2860
Q26738528-F4A783B0-0953-4CEF-B466-476C876C6025Q26829263-EA94054D-082F-4B2C-8EE3-C4C4893CBC53Q26865927-D80AE4D6-F721-42F3-BC7D-A4D7987ACBDFQ29883401-175D71D2-C72C-4172-943A-F9BFCE6A69DDQ35538429-713C702C-1770-487E-9E45-4CE1399A12B3Q35879510-4EF9EBE8-E851-4782-A096-B1DF963BEC90Q35927508-11A95B4B-AB91-4F0D-9E35-CD9F0FC167C9Q36928958-881FA978-0C26-4DEC-9E7E-FFA667687222Q37386327-B342C0C1-B383-4A77-AEA5-2DF77763F6A7Q37446629-BF1E7CBA-883B-4D36-8C2F-BDAD65AFD508Q37560927-5A4AE7FA-DFD4-4923-9BAB-2F069D9D7507Q37634419-ED3A25BC-FE89-44F0-BCB8-BF9D4CAB4789Q38003156-F27AFB12-20C9-4413-8D96-77E9CCB459A5Q38869922-1627C79B-609B-4A77-B615-210E764E9172Q39564395-0DD14984-56D5-4799-8B84-9852B0533DA2Q39665168-7F3A5CB7-CF83-4CB9-9356-217E9C4E0E63Q42178970-814CFDB7-2313-4E22-95D2-CD6131C5708CQ42782251-E167E424-401D-4D6D-A684-5C8D3E5A5B4CQ47142505-D2F4BD69-FE62-40A2-9FD7-9CA97269AF0DQ47442621-FF4FE916-3B0A-44CE-887D-0644C0ADDE99Q48263650-D223C52F-EE78-4439-B725-EB24ABCAB826
P2860
Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer.
@ast
Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer.
@en
Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer.
@nl
type
label
Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer.
@ast
Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer.
@en
Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer.
@nl
altLabel
Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer
@en
prefLabel
Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer.
@ast
Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer.
@en
Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer.
@nl
P2093
P1476
Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer.
@en
P2093
P2860
P2888
P304
P356
10.1007/S00280-008-0838-Z
P407
P577
2009-05-01T00:00:00Z
P6179
1021847997